Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Knowing which debts to pay off first is crucial for effective financial management. Explore the best approaches to prioritize your repayments.
25,509 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
This week’s CPI data could tilt policy expectations: a hotter print may bolster a hawkish stance from the new Fed lea...
On-chain signals point to bitcoin seller exhaustion? on-chain as macro relief takes hold, suggesting late-stage capit...
Healthcare megacaps Pfizer and Johnson & Johnson continue to deliver quarterly dividends that can generate reliable i...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Investors are buzzing about a SpaceX and TESLA merger. This piece dives into what a deal could mean for AI, energy, a...
SpaceX's SPCX debut fueled by momentum faces GE Aerospace's steady earnings machine. Investors grapple with spcx inve...
A veteran Southern California luxury team is switching brokerages, moving to Sotheby’s International Realty – Monteci...
Firms across tech and logistics are testing cheaper Chinese AI models as U.S. rivals grow pricier. The move spans sta...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
Green Brick Partners stands out in a tougher housing market thanks to a land-heavy model and strict debt discipline, ...